Results 71 to 80 of about 3,403 (193)
An overview of dehydroepiandrosterone (EM-760) as a treatment option for genitourinary syndrome of menopause [PDF]
, 2020 Introduction: Dyspareunia caused by vulvovaginal atrophy is a primary symptom of genitourinary syndrome of menopause (GSM), a chronic, progressive medical condition that results from estrogen and androgen deficiency at menopause.
Holton, Michelle, DO
core
Non-hormonal Treatment for Genitourinary Syndrome of Menopause
Guoji laonian yixue zazhiGenitourinary syndrome of menopause（GSM） is a symptom of external genitalia, urinary system, and sexual disorders in perimenopausal and postmenopausal women.
Gao bo, Sun Wei, Fan Xiaoguang, Duan Kun
doaj +1 more source
Systemic Therapy Management Strategies for Early‐Stage Breast Cancer in Australia
Asia-Pacific Journal of Clinical Oncology, EarlyView.Advances in systemic therapy for early‐stage breast cancer in Australia highlight genomic‐guided decisions, subtype‐specific strategies, and emerging targeted and immunotherapies, shaping personalized and de‐escalated treatment approaches. ABSTRACT Breast cancer is the most common cancer among Australian women, with early‐stage disease (Stages I, II ...
Nicholas Zdenkowski +6 more
wiley +1 more source
British Journal of Clinical Psychology, EarlyView.Abstract Objectives To synthesize current evidence and provide clinically actionable recommendations for integrating menstrual cycle‐related processes—particularly hormone sensitivity, Premenstrual Dysphoric Disorder (PMDD) and Premenstrual Exacerbation (PME)—into psychological assessment, formulation and treatment.
Ellen R. Lambert +2 more
wiley +1 more source
Drugs in Context, 2020 Pelvic floor muscle atrophy and collagen loss in connective tissue due to declining estrogen production in women as they age may underlie the increasing prevalence of urge and stress incontinence.
Zuramis Estrada Blanco +2 more
doaj +1 more source
HIV Medicine, EarlyView.Abstract Background Data on women ageing with HIV in Australia are limited, particularly regarding those in midlife and experiencing menopause. The aim of this study is to describe the demographic characteristics of cisgender women living with HIV who attend the Alfred Hospital, Monash Medical Centre and Melbourne Sexual Health Centre for primary HIV ...
Anna B. Pierce +5 more
wiley +1 more source
Women in space: A review of known physiological adaptations and health perspectives
Experimental Physiology, EarlyView.Abstract Exposure to the spaceflight environment causes adaptations in most human physiological systems, many of which are thought to affect women differently from men. Since only 11.5% of astronauts worldwide have been female, these issues are largely understudied.
Millie Hughes‐Fulford +4 more
wiley +1 more source
Medicina, 2019 Sexual function worsens with advancing menopause status. The most frequently reported symptoms include low sexual desire (40−55%), poor lubrication (25−30%) and dyspareunia (12−45%), one of the complications of genitourinary syndrome of
Irene Scavello +3 more
doaj +1 more source
Menopause and vascular endothelial health: Is it all about the oestrogen?
Experimental Physiology, EarlyView.Abstract Cardiovascular disease (CVD) is a leading cause of mortality in women, and CVD risk is accelerated during the menopause transition. This acceleration has traditionally been attributed to the hallmark decline in oestradiol with menopause. However, the menopause transition is also characterized by changes in other sex hormones that exert effects
Virginia R. Nuckols +4 more
wiley +1 more source
Food Frontiers, Volume 7, Issue 4, July 2026.The schematic diagram illustrating the improvement mechanisms of six typical FMH substances and their main active ingredients in different sleep disorders. ABSTRACT Sleep integrates many brain and peripheral processes, profoundly influencing well‐being.
Wenjing Wen +9 more
wiley +1 more source